LBH589对肾癌细胞株OS-RC-2增殖的影响及机制探讨
2016-01-20马俊健陈婷刘彬徐米清广州医科大学附属第二医院广州54002广州市番禺区妇幼保健院广州心血管疾病研究所
马俊健,陈婷,刘彬,徐米清( 广州医科大学附属第二医院,广州5400;2广州市番禺区妇幼保健院; 广州心血管疾病研究所)
LBH589对肾癌细胞株OS-RC-2增殖的影响及机制探讨
马俊健1,2,陈婷1,刘彬3,徐米清1
( 1广州医科大学附属第二医院,广州511400;2广州市番禺区妇幼保健院; 3广州心血管疾病研究所)
摘要:目的观察LBH589对肾癌细胞株OS-RC-2细胞增殖的影响,并探讨其机制。方法将人肾癌细胞株OS-RC-2细胞分为DMSO组、N-乙酰半胱氨酸( NAC)组、LBH589组和NAC + LBH589组,NAC组加入5 mmol/L NAC刺激2 h,LBH489组加入50 nmol/L LBH589刺激48 h,NAC + LBH589组先加入5 mmol/L NAC预处理2 h,洗脱后再以50 nmol/L LBH589刺激48 h。EdU法测算细胞增殖情况,流式细胞术检测细胞凋亡、活性氧簇( ROS),Western blotting法检测细胞p-STAT3、Cyclin D1蛋白。结果DMSO组、NAC组、LBH589组、NAC + LBH589组EdU染色阳性细胞比例分别为53%±4%、52%±5%、7%±3%、29%±6%,细胞凋亡率分别为0.25%±0.13%、0.18%±0.15%、11.35%±2.40%、1.92%±0.63%,ROS分别为0.60%±0.26%、0.33%±0.25%、12.2%± 2.65%、5.33%±1.05%,DMSO组、NAC + LBH589组与LBH589组比较,P均<0.05。DMSO组、NAC组、LBH589组、NAC + LBH589组p-STAT3相对表达量分别为1.00±0.07、1.02±0.07、0.49±0.04、0.52±0.05,Cyclin D1相对表达量分别为1.00±0.08、1.03±0.08、0.45±0.04、0.49±0.03,DMSO组与LBH589组比较,P均<0.05。结论LBH589对OS-RC-2肾癌细胞生长有抑制作用,其可能与诱导细胞凋亡、抑制细胞增殖、升高ROS水平有关。LBH589能抑制STAT3信号通路,进而使Cyclin D1表达下降,而LBH589诱导ROS升高不是通过抑制STAT3信号通路从而使肾癌细胞生长抑制。
关键词:肾肿瘤;肾癌;细胞增殖;细胞凋亡;组蛋白去乙酰化酶抑制剂
Effect of LBH589 on cell proliferation of renal carcinoma cell line OS-RC-2 and its mechanism
MA Jun-jian1,CHEN Ting,LIU Bin,LI Ai-qun,XU Mi-qing
( 1 The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou 511400,China)
Abstract:Objective To observe the influences of LBH589 on cell proliferation of renal cancer cell line OS-RC-2 and to explore its mechanism.Methods OS-RC-2 cells were divided into the DMSO group,N-acetyl cysteine ( NAC) group,LBH589 group and NAC +LBH589 group.NAC group was stimulated with 5 mmol/L of NAC for 2 h,LBH489 group was stimulated with 50 nmol/L of LBH589 for 48 h,and the NAC +LBH589 group was pre-treated with 5 mmol/L of NAC for 2 h and then after elution,the group was stimulated with 50 nmol/L of LBH589 for 48 h.EdU assay was used to measure cell proliferation,flow cytometry was used to detect the apoptosis and reactive oxygen species ( ROS),while Western blotting was used to detect p-STAT3 and Cyclin D1 proteins.Results The proportions of positive Edu cells in the DMSO group,NAC group,LBH589 group and NAC +LBH589 group were respectively 53%±4%,52%±5%,7%±3% and 29%±6%.The apoptosis rates of the corresponding groups were 0.25%±0.13%,0.18%±0.15%,11.35%±2.40% and 1.92%± 0.63%.ROS of the corresponding groups were 0.60%±0.26%,0.33%±0.25%,12.2%±2.65% and 5.33%± 1.05%.Significant difference was found between the DMSO,NAC +LBH589 groups and the LBH589 group ( all P<0.05).The relative expression of p-STAT3 was 1.00±0.07,1.02±0.07,0.49±0.04 and 0.52±0.05 in the DMSO group,NAC group,LBH589 group and NAC +LBH589 group.The relative expression of Cyclin D1 was 1.00±0.08,1.03±0.08,0.45 ±0.04 and 0.49±0.03 in the corresponding groups.Significant difference was found between the DMSO group and the LBH589 group ( all P<0.05).Conclusions LBH589 inhibits the growth of renal cancer cell line OS-RC-2,which may be related to induction of apoptosis,inhibition of cell proliferation and the increased ROS level.LBH589 can inhibit STAT3 sig-
naling pathway,thus decrease the expression of Cyclin D1.However,LBH589-induced ROS increase is not achieved through the inhibition of STAT3 signaling pathway to inhibit the growth of renal cancer cells.
Key words:kidney neoplasms; renal cell carcinoma; cell proliferation; apoptosis; histone deacetylase inhibitor
肾细胞癌( RCC)的治疗以根治性手术为主,放疗及化疗效果不理想,手术后复发率大于20%[1]。因此,寻找和研发新的抗肾癌药物十分必要。组蛋白去乙酰化酶抑制剂( HDACIs)可通过细胞周期阻滞、诱导分化和凋亡等机制[2,3]对血液系统肿瘤和一些实体肿瘤有明显抑制作用[4,5]。但HDACIs对肾癌细胞抑制作用的研究尚未见报道。HDACIs能提高细胞内活性氧簇( ROS)水平,降低抗氧化系统作用,抑制肿瘤细胞增殖,诱导细胞凋亡。……
